Annual ROE
-25.03%
+16.74%+40.08%
December 31, 2022
Summary
- As of February 10, 2025, JNCE annual return on equity is -25.03%, with the most recent change of +16.74% (+40.08%) on December 31, 2022.
- During the last 3 years, JNCE annual ROE has fallen by -65.80% (-161.39%).
Performance
JNCE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-28.83%
+40.61%+58.48%
December 31, 2022
Summary
- As of February 10, 2025, JNCE quarterly return on equity is -28.83%, with the most recent change of +40.61% (+58.48%) on December 31, 2022.
- Over the past year, JNCE quarterly ROE has increased by +7.68% (+21.04%).
Performance
JNCE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
JNCE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.1% | +21.0% |
| 3 y3 years | -161.4% | -166.4% |
| 5 y5 years | +23.9% | -121.9% |
JNCE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +66.9% | at high | +140.9% |
| 5 y | 5-year | -161.4% | +66.9% | -166.4% | +140.9% |
| alltime | all time | -101.3% | +154.1% | -143.4% | +158.1% |
Jounce Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -25.03%(-40.1%) | -28.83%(-58.5%) |
| Sep 2022 | - | -69.44%(+16.5%) |
| Jun 2022 | - | -59.62%(+43.3%) |
| Mar 2022 | - | -41.61%(+14.0%) |
| Dec 2021 | -41.77%(+83.8%) | -36.51%(+226.6%) |
| Sep 2021 | - | -11.18%(+12.1%) |
| Jun 2021 | - | -9.97%(-60.3%) |
| Mar 2021 | - | -25.09%(-11.8%) |
| Dec 2020 | -22.72%(-155.7%) | -28.44%(-58.1%) |
| Sep 2020 | - | -67.91%(-558.9%) |
| Jun 2020 | - | 14.80%(-51.3%) |
| Mar 2020 | - | 30.41%(-29.9%) |
| Dec 2019 | 40.77% | 43.40%(-34.6%) |
| Sep 2019 | - | 66.37%(-328.7%) |
| Jun 2019 | - | -29.02%(+13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -25.66%(+11.2%) |
| Dec 2018 | -20.19%(-38.7%) | -23.07%(-11.7%) |
| Sep 2018 | - | -26.12%(+23.9%) |
| Jun 2018 | - | -21.09%(+14.5%) |
| Mar 2018 | - | -18.42%(+41.8%) |
| Dec 2017 | -32.91%(+72.6%) | -12.99%(+754.6%) |
| Sep 2017 | - | -1.52%(-113.9%) |
| Jun 2017 | - | 10.97%(-579.0%) |
| Mar 2017 | - | -2.29%(-88.5%) |
| Dec 2016 | -19.07%(-70.0%) | -19.96%(-62.4%) |
| Sep 2016 | - | -53.14%(-28.6%) |
| Jun 2016 | - | -74.41%(+58.7%) |
| Mar 2016 | - | -46.88%(+107.4%) |
| Dec 2015 | -63.61%(-103.2%) | -22.60% |
| Dec 2014 | 1965.61% | - |
FAQ
- What is Jounce Therapeutics annual return on equity?
- What is the all time high annual ROE for Jounce Therapeutics?
- What is Jounce Therapeutics annual ROE year-on-year change?
- What is Jounce Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Jounce Therapeutics?
- What is Jounce Therapeutics quarterly ROE year-on-year change?
What is Jounce Therapeutics annual return on equity?
The current annual ROE of JNCE is -25.03%
What is the all time high annual ROE for Jounce Therapeutics?
Jounce Therapeutics all-time high annual return on equity is 1965.61%
What is Jounce Therapeutics annual ROE year-on-year change?
Over the past year, JNCE annual return on equity has changed by +16.74% (+40.08%)
What is Jounce Therapeutics quarterly return on equity?
The current quarterly ROE of JNCE is -28.83%
What is the all time high quarterly ROE for Jounce Therapeutics?
Jounce Therapeutics all-time high quarterly return on equity is 66.37%
What is Jounce Therapeutics quarterly ROE year-on-year change?
Over the past year, JNCE quarterly return on equity has changed by +7.68% (+21.04%)